Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-26T00:46:19.072Z Has data issue: false hasContentIssue false

Fontan failure: phenotypes, evaluation, management, and future directions

Published online by Cambridge University Press:  22 June 2022

Ujjwal Kumar Chowdhury*
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
Niwin George
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
Lakshmi Kumari Sankhyan
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, Bilaspur, India
Doniparthi Pradeep
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
Chaitanya Chittimuri
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
Abhinavsingh Chauhan
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
Niraj Nirmal Pandey
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
Shikha Goja
Affiliation:
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
*
Author for correspondence: Dr U. K. Chowdhury, M.Ch., Diplomate NB, Department of Cardiothoracic and Vascular Surgery, AIIMS, New Delhi, 110029, India. Tel: +91 11 26594835; Fax: +91 11 26588641. E-mail: ujjwalchowdhury@gmail.com

Abstract

Objectives:

Management of “failing” and “failed” Fontan circulation, particularly the indications, timing, and type of re-intervention, currently remains nebulous. Factors contributing to pathogenesis and mortality following Fontan procedure differ between children and adults.

Methods:

Since organ systems in individual patients are affected differently, we searched the extant literature for a “failing” and “failed” Fontan reviewing the clinical phenotypes, diagnostic modalities, pharmacological, non-pharmacological, and surgical techniques employed, and their outcomes.

Results:

A total of 410 investigations were synthesised. Although proper candidate selection, thoughtful technical modifications, timely deployment of mechanical support devices, tissue-engineered conduits, and Fontan takedown have decreased the peri-operative mortality from 9 to 15% and 1 to 3% per cent in recent series, pernicious changes in organ function are causing long-term patient attrition. In the setting of a failed Fontan circulation, literature documents three surgical options: Fontan revision, Fontan conversion, or cardiac transplantation. The reported morbidity of 25% and mortality of 8–10% among Fontan conversion continue to improve in select institutions. While operative mortality following cardiac transplantation for Fontan failure is 30% higher than for other CHDs, there is no difference in long-term survival with actuarial 10-year survival of around 54%. Mechanical circulatory assistance, stem cells, and tissue-engineered Fontan conduit for destination therapy or as a bridge to transplantation are in infancy for failing Fontan circulation.

Conclusions:

An individualised management strategy according to clinical phenotypes may delay the organ damage in patients with a failing Fontan circulation. At present, cardiac transplantation remains the last stage of palliation with gradually improving outcomes.

Type
Review
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

All authors have contributed equally to this work

References

Fontan, F, Kirklin, JW, Fernandez, G, et al. Outcome after a “perfect” Fontan operation. Circulation 1990; 81: 15201536.CrossRefGoogle ScholarPubMed
Caneo, LF, Turquetto, LR, Neirotti, RA, et al. Lessons learned from a critical analysis of the Fontan operation over three decades in a single institution. World J Pediatr Congenit Heart Surg 2017; 8: 376384.CrossRefGoogle ScholarPubMed
Kotani, Y, Chetan, D, Zhu, J, et al. Fontan failure and death in contemporary Fontan circulation: analysis from the last two decades. Ann Thorac Surg 2018; 105: 12401247.CrossRefGoogle ScholarPubMed
Rychik, J, Atz, AM, Celermajer, DS, et al. Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation 2019; 140: e234e284.CrossRefGoogle Scholar
Zentner, D, Celermajer, DS, Gentles, T, et al. Management of people with a Fontan circulation: a cardiac society of Australia and New Zealand position statement. Heart Lung Circ 2020; 29: 539.CrossRefGoogle ScholarPubMed
Khairy, P, Fernandes, SM, Mayer, JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 8592.CrossRefGoogle ScholarPubMed
Schilling, C, Dalziel, K, Nunn, R, et al. The Fontan epidemic: population projections from the Australia and New Zealand Fontan Registry. Int J Cardiol 2016; 219: 1419.CrossRefGoogle ScholarPubMed
Stout, KK, Broberg, CS, Book, WM, et al. Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation 2016; 133: 770801.CrossRefGoogle ScholarPubMed
Deal, BJ, Jacobs, ML. Management of the failing Fontan circulation. Heart 2012; 98: 10981104.CrossRefGoogle ScholarPubMed
Hebson, CL, McCabe, NM, Elder, RW, et al. Hemodynamic phenotype of the failing Fontan in an adult population. Am J Cardiol 2013; 112: 19431947.CrossRefGoogle Scholar
Book, WM, Shaddy, RE. Medical therapy in adults with congenital heart disease. Heart Fail Clin 2014; 10: 167178.CrossRefGoogle ScholarPubMed
Elder, RW, McCabe, NM, Hebson, C, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol 2013; 168: 37643769.CrossRefGoogle ScholarPubMed
van Melle, JP. Surgical options after Fontan failure. Heart 2016; 102: 11271133.CrossRefGoogle ScholarPubMed
Mori, H, Park, IS, Yamagishi, H, et al. Sildenafil reduces pulmonary vascular resistance in single ventricular physiology. Int J Cardiol 2016; 221: 122127.CrossRefGoogle ScholarPubMed
Stewart, RD, Pasquali, SK, Jacobs, JP, et al. Contemporary Fontan operation: association between early outcome and type of cavopulmonary connection. Ann Thorac Surg 2012; 93: 12541261.CrossRefGoogle ScholarPubMed
Murphy, MO, Glatz, AC, Goldberg, DJ, et al. Management of early Fontan failure: a single-institution experience. Eur J Cardiothorac Surg 2014; 46: 458464.CrossRefGoogle ScholarPubMed
Deal, BJ, Costello, JM, Webster, G, et al. Intermediate-term outcome of 140 consecutive Fontan conversions with arrhythmia operations. Ann Thorac Surg 2016; 101: 717724.CrossRefGoogle ScholarPubMed
Ovroutski, S, Dahnert, I, Alexi-Meskishvili, V, et al. Preliminary analysis of arrhythmias after the Fontan operation with extracardiac conduit compared with intra-atrial lateral tunnel. Thorac Cardiovasc Surg 2001; 49: 334337.CrossRefGoogle ScholarPubMed
Gentles, TL, Mayer, JE, Gauvreau, K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997; 114: 376391.CrossRefGoogle ScholarPubMed
Mavroudis, C, Backer, CL, Deal, BJ, et al. Evolving anatomic and electrophysiologic considerations associated with Fontan conversion. Semin Thorac Cardiovasc Surg 2007; 10: 136145.CrossRefGoogle Scholar
Mavroudis, C, Deal, BJ. Fontan conversion: literature review and lessons learned over 20 years. World J Pediatr Congenit Heart Surg 2016; 7: 192198.CrossRefGoogle ScholarPubMed
Akbari Asbagh, P, Navabi Shirazi, MA, Soleimani, A, et al. Incidence and etiology of chylothorax after congenital heart surgery in children. J Tehran Heart Cent 2014; 9: 5963.Google ScholarPubMed
Shah, MJ, Rychik, J, Fogel, MA, et al. Pulmonary AV malformations after superior cavopulmonary connection: resolution after inclusion of hepatic veins in the pulmonary circulation. Ann Thorac Surg 1997; 63: 960963.CrossRefGoogle ScholarPubMed
Hraška, V. Decompression of thoracic duct: new approach for the treatment of failing Fontan. Ann Thorac Surg 2013; 96: 709711.CrossRefGoogle ScholarPubMed
Hess, J, Kruizinga, K, Bijleveld, CM, et al. Protein-losing enteropathy after Fontan operation. J Thorac Cardiovasc Surg 1984; 88: 606609.CrossRefGoogle ScholarPubMed
Meadows, J, Gauvreau, K, Jenkins, K. Lymphatic obstruction and protein-losing enteropathy in patients with congenital heart disease. Congenit Heart Dis 2008; 3: 269276.CrossRefGoogle ScholarPubMed
Ostrow, AM, Freeze, H, Rychik, J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006; 82: 695700.CrossRefGoogle ScholarPubMed
Feldt, RH, Driscoll, DJ, Offord, KP, et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 1996; 112: 672680.CrossRefGoogle ScholarPubMed
Mertens, L, Hagler, DJ, Sauer, U, et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg 1998; 115: 10631073.CrossRefGoogle Scholar
Rychik, J, Goldberg, D, Rand, E, et al. End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis. Cardiol Young 2013; 23: 831840.CrossRefGoogle ScholarPubMed
Supplementary material: File

Chowdhury et al. supplementary material

Chowdhury et al. supplementary material

Download Chowdhury et al. supplementary material(File)
File 95.9 KB